Acrannolife | Trunome Liquid Biopsy | Post Transplant Monitoring | Covid-19 Testing

Welcome to Acrannolife

Reshaping Chronic Disease Care

Acrannolife has a dedicated research and development team of scientists from across the world intending to provide better clinical outcomes with faster results and positively impact patients’ lives.

As Featured IN:

Trunome : Revolutionary Diagnostic test

Trunome enables the early detection and monitoring of chronic diseases through a blood test. Being the first and entirely made-in-India technology platform in Asia, it is protected by patents granted in the United States and is known for its high effectiveness and accuracy in monitoring organ health.

Leading with Purpose and Passion

Acrannolife’s core focus is on developing a technology platform for the detection and monitoring of chronic and infectious diseases, with the goal of disrupting the current process through early detection, decentralizing testing, and democratizing access to make it accessible to patients globally.

Agragesh Ramani & Avinash Ramani

Co-founder, CSO & Co-founder, CEO

COVIQWIK is made in collaboration with ICMR

Trunome is a revolutionary non-invasive diagnostic test that enables the early detection and monitoring of chronic diseases through a blood test. Being the first and entirely made-in-India technology platform in Asia, it is protected by patents granted in the United States and is known for its high effectiveness and accuracy in monitoring organ health.

Trunome-Tx

Trunome-Tx specializes in offering solutions for post-transplant patients organ health. An innovative diagnostic test called Trunome is a non-invasive method that helps in monitor status of solid organ transplants through a blood test.An effective way to monitor the health of transplanted solid organs such as the kidney, liver, heart, lungs, and pancreas. The organization offers specialized care solutions to support post-transplant recovery and long-term health.

News & Media

Challenges Faced by Patients Post Solid Organ Transplant

Solid organ transplantation offers a second chance at life for patients with end-stage organ failure. Whether it’s a heart, kidney, liver, or lung transplant, the surgery is just the beginning.

Celebrating a Decade of Innovation and Excellence at AcrannoLife Genomics

On July 31st, 2024, AcrannoLife Genomics celebrated a significant milestone—10 years of innovation, dedication, and impact. To mark the occasion, our team gathered at the Radisson Blu Bay Resort in Mahabalipuram

ICMR-NIV develops cost-effective, rapid RT LAMP Covid test kit; can give results in 30-40 mins

The Indian Council of Medical Research-National Institute of Virology (ICMR-NIV) Mumbai unit has developed a cost-effective and rapid RT LAMP Covid-19 testing kit that

FAQs

Early detection refers to identifying chronic diseases at their initial stages before they develop into more severe or complicated health issues. This can involve routine screenings, assessments, and monitoring of risk factors.

Early detection allows for timely interventions, which can significantly improve outcomes, reduce complications, and enhance the quality of life for individuals with chronic diseases. It can also lead to lower healthcare costs over time.

Common chronic diseases that benefit from early detection include diabetes, hypertension, heart disease, chronic respiratory diseases, and certain cancers.

Recommended screening tests may include blood pressure checks, cholesterol tests, blood glucose tests, mammograms, colonoscopies, and lung function tests, depending on your age, gender, and risk factors.

Our Team

Agragesh Ramani

Co-founder, CSO

Avinash Ramani

Co-founder, CEO

Dr.Sunil Shroff

Medical Advisor